Ugeskrift for laeger
-
Ugeskrift for laeger · Feb 2001
Review[Strategies to reduce the use of perioperative allogenic blood].
Allogenic blood transfusion carries the risk of immunological and non-immunological adverse effects. Consequently, blood transfusion should be limited to situations where alternatives are not available. ⋯ The effectiveness of a number of these alternatives needs to be documented and potential adverse effects clarified. The acceptance of a lower haemoglobin level as the transfusion trigger value is perhaps the most important factor in reducing the need for peri-operative allogenic blood transfusion.